Comparing COVID-19 Vaccine Schedule Combinations in Adolescents (Com-COV3)

Project summary:

Com-COV3 is being carried out by the University of Oxford. The study will help us understand the best way to immunise adolescents (12 to 16 year-olds) against COVID-19. The study is particularly interested in what are the best options for the second dose of COVID-19 vaccines. This study is being done at the request of the UK Vaccine Task Force to provide information to the Joint Committee for Vaccination and Immunisation.


UK Vaccine Task Force, National Institute of Health Research (NIHR), Novavax (vaccine supply)

Leader researcher:

Associate Professor Matthew Snape

Lead institution:

University of Oxford

Vaccine type:


Recruitment for clinical trial open: